Primus inter pares

First MSMU as a matter of FACT

March 23-24. The University Clinic №1 received the all-Russian open scientific conference 1st All-Russian Forum of AntiCoagulant Therapy (FACT) 2016 promoting the latest achievements dealing with thromboembolic complications treatment.
The conference, organized by the Faculty Therapy Department №1 and supported by the Ministry of Health of the Russian Federation and the Russian Federal Property Fund, was held for the first time and became the industrial hit: physicians, cardiologists, neurologists, vascular surgeons, gynecologists and obstetricians were keen to take part in the event. The total of 506 participants from 27 cities of Russia: Moscow, St. Petersburg, Arkhangelsk, Smolensk, Yekaterinburg, Novosibirsk, Tver, Vladivostok, Irkutsk etc., and also eight foreign participants from the UK, Estonia, Moldova and Ukraine gathered in First MSMU.
The conference was opened by Vice-rector for scientific work Sergei Shevchenko noting that First MSMU is the only medical university featuring in the list of leading Russian educational establishments running Project 5-100 aimed at enhancing domestic academic excellence. In this connection, the internal and international First MSMU, where the specialists in different medical fields enjoy the opportunity to discuss new clinical studies to share accumulated experience and develop their potential, acquires positively crucial importance.
Professor of the Faculty Therapy Department №1 Dmitry Napalkov made reported on the latest clinical research discoveries in the field of anticoagulant therapy in cardiology.
Plenum proceeded the lecture on anticoagulant therapy in neurology articulated by the head of Nervous Diseases and Neurosurgery Chair at First MSMU Professor Vladimir Parfenov, whilst the head of the Obstetrics and Gynaecology Chair Alexander Makatsaria spoke on pathophysiological bases of thrombophilia and pregnancy complications.
Next thing was The Overview of New Data on Pathogenesis and Approaches to the Treatment of Deep Vein Thrombosis by director of Laboratory of Cardiovascular Sciences (Birmingham), Alexander Brill.
Consisting of 52 oral presentations in toto, the scientific program included 9 breakout sessions, 9 satellite symposia and a workshop. The conference was accompanied with the exhibition of new products and latest achievements of the world's leading manufacturers of anticoagulants.
The event is meant to become annual, so next year it is planned to involve vascular surgeons, orthopedic trauma and pediatricians.
www.anticoagulants.ru
fact16_24_76.jpg
fact16_24_66.jpg
fact16_24_160.jpg
glavnaya.jpg
31.03.2016

Назад